BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3988966)

  • 1. The dexamethasone suppression test in agoraphobia.
    Peterson GA; Ballenger JC; Cox DP; Hucek A; Lydiard RB; Laraia MT; Trockman C
    J Clin Psychopharmacol; 1985 Apr; 5(2):100-2. PubMed ID: 3988966
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dexamethasone suppression test in patients with panic attacks.
    Bridges M; Yeragani VK; Rainey JM; Pohl R
    Biol Psychiatry; 1986 Jul; 21(8-9):853-5. PubMed ID: 3730467
    [No Abstract]   [Full Text] [Related]  

  • 3. [The dexamethasone suppression test in agoraphobia with panic attacks. 30 cases].
    Cottraux J; Claustrat B
    Encephale; 1984; 10(6):267-72. PubMed ID: 6529933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal escape from dexamethasone suppression in agoraphobia with panic attacks.
    Coryell W; Noyes R; Clancy J; Crowe R; Chaudhry D
    Psychiatry Res; 1985 Aug; 15(4):301-11. PubMed ID: 2866558
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The significance of HPA axis disturbance in panic disorder.
    Coryell W; Noyes R; Schlechte J
    Biol Psychiatry; 1989 Apr; 25(8):989-1002. PubMed ID: 2720018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The dexamethasone suppression test in panic disorder and agoraphobia.
    Curtis GC; Cameron OG; Nesse RM
    Am J Psychiatry; 1982 Aug; 139(8):1043-6. PubMed ID: 7091428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The dexamethasone suppression test in panic disorder and major depressive episodes.
    Faludi G; Kaskó M; Perényi A; Arató M; Frecska E
    Biol Psychiatry; 1986 Sep; 21(11):1008-14. PubMed ID: 3741916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal urinary free cortisol and plasma MHPG in panic disorder: clinical and theoretical implications.
    Uhde TW; Joffe RT; Jimerson DC; Post RM
    Biol Psychiatry; 1988 Mar; 23(6):575-85. PubMed ID: 2833321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hypothalamic-pituitary-adrenal system in panic disorder.
    Goldstein S; Halbreich U; Asnis G; Endicott J; Alvir J
    Am J Psychiatry; 1987 Oct; 144(10):1320-3. PubMed ID: 3661766
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal dexamethasone suppression test in daily chronic headache sufferers.
    Martignoni E; Facchinetti F; Manzoni GC; Petraglia F; Nappi G; Genazzani AR
    Psychiatry Res; 1986 Sep; 19(1):51-7. PubMed ID: 3786599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Agoraphobia and the dexamethasone suppression test: atypical depression?
    Whiteford HA; Evans L
    Aust N Z J Psychiatry; 1984 Dec; 18(4):374-7. PubMed ID: 6596945
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The DST in psychiatric outpatients with generalized anxiety disorder, panic disorder, or primary affective disorder.
    Avery DH; Osgood TB; Ishiki DM; Wilson LG; Kenny M; Dunner DL
    Am J Psychiatry; 1985 Jul; 142(7):844-8. PubMed ID: 4014507
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The dexamethasone suppression test in inpatients with panic disorder or agoraphobia with panic attacks.
    Grunhaus L; Tiongco D; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Apr; 22(4):517-21. PubMed ID: 3567265
    [No Abstract]   [Full Text] [Related]  

  • 14. Serial dexamethasone suppression tests in simultaneous panic and depressive disorders.
    Grunhaus L; Flegel P; Haskett RF; Greden JF
    Biol Psychiatry; 1987 Mar; 22(3):332-8. PubMed ID: 3814682
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship of dexamethasone suppression to psychological test variables.
    Danahy SA; Schwartz BD; Willard SG; Winstead DK
    J La State Med Soc; 1986 Jan; 138(1):38-43. PubMed ID: 3950587
    [No Abstract]   [Full Text] [Related]  

  • 16. The dexamethasone suppression test in depressed and non-depressed geriatric medical inpatients.
    Magni G; Schifano F; De Leo D; De Dominicis MG; Garbin A; Zangaglia O
    Acta Psychiatr Scand; 1986 May; 73(5):511-4. PubMed ID: 3751656
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The influence of weight loss on the dexamethasone suppression test.
    Yerevanian BI; Baciewicz GJ; Iker HP; Privitera MR
    Psychiatry Res; 1984 Jun; 12(2):155-60. PubMed ID: 6591220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is conversion disorder biologically related with depression?: a DST study.
    Tunca Z; Fidaner H; Cimilli C; Kaya N; Biber B; Yeşil S; Ozerdem A
    Biol Psychiatry; 1996 Feb; 39(3):216-9. PubMed ID: 8837984
    [No Abstract]   [Full Text] [Related]  

  • 19. Prediction of outcome in depressed patients by weekly monitoring with the dexamethasone suppression test.
    Schweitzer I; Maguire KP; Gee AH; Tiller JW; Biddle N; Davies B
    Br J Psychiatry; 1987 Dec; 151():780-4. PubMed ID: 3502804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salivary cortisol levels in persons with and without different anxiety disorders.
    Vreeburg SA; Zitman FG; van Pelt J; Derijk RH; Verhagen JC; van Dyck R; Hoogendijk WJ; Smit JH; Penninx BW
    Psychosom Med; 2010 May; 72(4):340-7. PubMed ID: 20190128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.